Location History:
- Sandby, SE (2009)
- Lund, SE (2009)
Company Filing History:
Years Active: 2009
Title: Jörgen Ohlsson: Innovator in Neuropsychiatric Treatments
Introduction
Jörgen Ohlsson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neuropsychiatric disorders. With a total of 4 patents to his name, Ohlsson's work is recognized for its innovative approach to drug synthesis and application.
Latest Patents
Ohlsson's latest patents focus on analogs of clozapine, which include pharmaceutically acceptable salts, esters, amides, or prodrugs. These patents detail methods of synthesizing these analogs and their use in treating neuropsychiatric disorders. In some embodiments, the analogs are described as amino substituted diaryl[a,d]cycloheptenes, showcasing Ohlsson's commitment to advancing therapeutic options in mental health.
Career Highlights
Throughout his career, Ohlsson has been associated with Acadia Pharmaceuticals Inc., where he has played a pivotal role in research and development. His expertise in pharmacology and drug design has contributed to the company's mission of improving the lives of patients with serious neuropsychiatric conditions.
Collaborations
Ohlsson has collaborated with esteemed colleagues such as Fredrik Ek and Roger Olsson. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapeutic solutions.
Conclusion
Jörgen Ohlsson's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving treatments for neuropsychiatric disorders, making him a significant figure in the field.